GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greater Cannabis Co Inc (OTCPK:GCAN) » Definitions » Gross Margin %

Greater Cannabis Co (Greater Cannabis Co) Gross Margin % : 0.00% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Greater Cannabis Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Greater Cannabis Co's Gross Profit for the three months ended in Mar. 2024 was $0.00 Mil. Greater Cannabis Co's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, Greater Cannabis Co's Gross Margin % for the quarter that ended in Mar. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Greater Cannabis Co's Gross Margin % or its related term are showing as below:


During the past 8 years, the highest Gross Margin % of Greater Cannabis Co was -657.14%. The lowest was -657.14%. And the median was -657.14%.

GCAN's Gross Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 47.02
* Ranked among companies with meaningful Gross Margin % only.

Greater Cannabis Co had a gross margin of N/A% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Greater Cannabis Co was 0.00% per year.


Greater Cannabis Co Gross Margin % Historical Data

The historical data trend for Greater Cannabis Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greater Cannabis Co Gross Margin % Chart

Greater Cannabis Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial -657.14 - - - -

Greater Cannabis Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Greater Cannabis Co's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Greater Cannabis Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greater Cannabis Co's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greater Cannabis Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Greater Cannabis Co's Gross Margin % falls into.



Greater Cannabis Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Greater Cannabis Co's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

Greater Cannabis Co's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Greater Cannabis Co  (OTCPK:GCAN) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Greater Cannabis Co had a gross margin of N/A% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Greater Cannabis Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Greater Cannabis Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Greater Cannabis Co (Greater Cannabis Co) Business Description

Traded in Other Exchanges
N/A
Address
15 Walker Avenue, Suite 101, Baltimore, MD, USA, 21208
Greater Cannabis Co Inc ia a biopharmaceutical company focused on the development and commercialization of innovative cannabinoid therapeutics. The firm focuses on cannabis-related investment and development opportunities through direct equity investments, joint ventures, licensing agreements, or acquisitions and also on commercializing its eluting transmucosal patch platform (ETP) technology. The company's operations are focused on its online store, GCC Superstore. The firm is involved in additional research and development of innovative cannabinoid-based therapeutics.
Executives
Jimmy Wayne Anderson 10 percent owner 501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701